secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2022-06-28T23:59:59+00:00
Accession:  0001104659-22-075294
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 500,000-share increase and extension of 2015 Stock Incentive Plan to 2032
--------------------------------------------------------------------------------

- Plan share reserve increased by 500,000 to 11.5M shares; expiration extended to April 25, 2032.
- All 9 director nominees elected with majority vote; advisory say-on-pay passed with 38.9M for, 0.7M against.
- Plan amendment received 34.8M votes for (85.8% of votes cast); Ernst & Young ratified as auditor for 2022.
- Amendment effective June 27, 2022; prior plan was approved by shareholders in June 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465922075294/0001104659-22-075294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465922075294/tm2219474d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-075294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer